dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Prager, Gerald W |
dc.contributor.author | Westphalen, C Benedikt |
dc.contributor.author | D'Esquermes, Nathalie |
dc.contributor.author | Ferreras, Anabel |
dc.contributor.author | Macarulla Mercadé, Teresa |
dc.contributor.author | Taieb, Julien |
dc.contributor.author | Melisi, Davide |
dc.date.accessioned | 2021-10-22T05:44:42Z |
dc.date.available | 2021-10-22T05:44:42Z |
dc.date.issued | 2020-01-20 |
dc.identifier.citation | Taieb J, Prager GW, Melisi D, Westphalen CB, D’Esquermes N, Ferreras A, et al. First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study. ESMO Open. 2020 Jan 20;5:e000587. |
dc.identifier.issn | 2059-7029 |
dc.identifier.uri | https://hdl.handle.net/11351/6435 |
dc.description | Europa oriental; Gemcitabina; Cáncer de páncreas |
dc.language.iso | eng |
dc.publisher | BMJ |
dc.relation.ispartofseries | ESMO Open;5 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Pàncrees - Càncer - Quimioteràpia |
dc.subject | Adenocarcinoma - Quimioteràpia |
dc.subject.mesh | Pancreatic Neoplasms |
dc.subject.mesh | Adenocarcinoma |
dc.subject.mesh | /drug therapy |
dc.title | First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/esmoopen-2019-000587 |
dc.subject.decs | neoplasias pancreáticas |
dc.subject.decs | adenocarcinoma |
dc.subject.decs | /farmacoterapia |
dc.relation.publishversion | https://doi.org/10.1136/esmoopen-2019-000587 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Taieb J] Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Sorbonne Paris Cité, Université Paris Descartes, Paris, France. [Prager GW] Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. [Melisi D] Digestive Molecular Clinical Oncology Research Unit, Department of Medicine, Università degli Studi di Verona, Verona, Veneto, Italy. [Westphalen CB] Department of Medicine III and Comprehensive Cancer Center Munich, University Hospital LMU Munich, Munich, Germany. [D'Esquermes N, Ferreras A] Genactis SAS, Mougins, France. [Macarulla T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 31958291 |
dc.identifier.wos | 000527764500006 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |